SAT KARTAR LIFE LIMITED Share Price

SAT KARTAR LIFE LIMITED Share Price

NSE: SATKARTAR
|
Pharmaceuticals
₹ 129.10
-₹1.40 (-1.07%)
1D
Last updated 31 Jul, 2026, 15:29 IST

SAT KARTAR LIFE LIMITED Share Price Today

As of 1 Aug 2026, SAT KARTAR LIFE LIMITED share price is ₹129.10. The stock opened at ₹130.50, compared to its previous close of ₹130.50. During today's trading session, SAT KARTAR LIFE LIMITED share price moved in the range of ₹128.05 to ₹130.50, with an average price of ₹129.28 for the day. Looking at its last 52-week, the stock has touched a low of ₹124.00 and a high of ₹219.80. On the performance front, SAT KARTAR LIFE LIMITED share price has declined by 11.94% over the last six months and is down 27.70% on a year-on-year basis.

₹128.05
1.07% down today
₹130.50
1D LOW
1D HIGH

SAT KARTAR LIFE LIMITED Returns Calculator

Circuit
L
H
₹103.25
₹154.85
52-week
L
H
₹124.00
₹219.80
Mkt Cap Cr
206.13
P/E
11.81
P/B
2.97
ROE
25.51%
D/E
0.04
ROCE
34.06%
Div. Yield
0.00%
EPS(TTM)
10.96
Turnover
2.80
EV/EBITDA
—
Net Margin
0.00%
Op. Margin
0.00%
ROA
—
Quick Ratio
0.00
Curr. Ratio
4.86
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Sat Kartar Life has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Sat Kartar Life appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
Sat Kartar Life earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,80,047.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories2,08,141.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,85,264.0086.6522.0325.49%1.6913.85%222.760.69%0.4158.70
Cipla1,18,992.0035.293.4411.27%0.0014.95%423.360.89%0.4543.52
Zydus Lifesciences1,11,272.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,10,374.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,06,427.0051.486.5311.74%0.3413.13%397.020.04%0.4449.37
Laurus Labs96,251.2088.2818.1616.77%0.4016.14%97.200.11%0.6713.72
Dr. Reddy's Laboratories95,516.1030.092.5211.07%0.1812.54%377.960.70%0.4138.68
Aurobindo Pharma91,502.4026.122.419.25%0.1911.76%391.140.25%0.4841.58

SAT KARTAR LIFE LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2026
Revenue163.68203.12
Operating profit13.1523.22
Net profit9.8217.1

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹162.92₹127.91₹82.97₹51.92
Other Income₹0.76₹0.20₹0.01₹0.39
Total Revenue₹163.68₹128.11₹82.98₹52.31
Total Expenses₹150.53₹119.52₹79.53₹50.80
Profit Before Tax₹13.15₹8.59₹3.44₹1.51
Tax₹3.34₹2.29₹0.94₹0.12
Profit After Tax₹9.82₹6.31₹2.51₹1.39
EPS - Basic₹7.37₹22.52₹3.58₹1.98
EPS - Diluted₹7.37₹22.52₹3.58₹1.98

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹13.15₹8.59₹3.44₹1.51
Income before WC changes₹15.31₹10.56₹5.26₹2.72
Change in Assets-₹14.55-₹3.78₹0.22₹0.10
Change in Liabilities-₹2.57₹3.22₹3.18-₹0.50
Change in WC-₹17.12-₹0.56₹3.41-₹0.40
Cash flow from Operations-₹5.07₹7.04₹7.97₹2.27
Cash flow from Investing-₹0.31-₹2.61-₹3.51-₹0.78
Cash flow from Financing₹33.56-₹2.57-₹4.88-₹1.19
Total Cash Flow₹28.18₹1.86-₹0.42₹0.30
Cash (Start of the year)₹2.52₹0.65₹1.08₹0.78
Cash (End of the year)₹30.70₹2.52₹0.65₹1.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹9.08₹9.80₹8.28₹5.70
Current Assets₹54.66₹11.95₹6.43₹6.69
Total Assets₹63.74₹21.75₹14.71₹12.39
Current Liabilities₹10.25₹11.80₹9.01₹5.26
Net Current Asset₹44.41₹0.15-₹2.58₹1.43
Non-Current Liabilities₹1.99₹0.52₹2.42₹6.36
Equity Capital₹51.50₹9.43₹3.27₹0.77
Total Equity & Liabilities₹63.74₹21.75₹14.71₹12.39
* All values are in INR Crore
Qty
Bid
800
129.05
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 800
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
38.04
Neutral
ATR (14)
5.19
Neutral
STOCH(9,6)
20.1
Bullish
STOCH RSI (14)
57.67
Neutral
ADX(9)
36.17
Bearish
UO(9)
41.39
Neutral
ROC(12)
-2.27
Bearish
WillR(14)
-79.9
Neutral
Period
Simple value
Exponential vaue
5D
129.4
130.32
10D
133.22
131.89
20D
133.99
135.47
50D
150.13
147.41
100D
165.59
156.58

About SAT KARTAR LIFE LIMITED

SAT KARTAR LIFE LIMITED Share Price
ISIN
INE0NB801022
Sector Market Cap
₹ 206.13 Cr

Sat Kartar Shopping Ltd is an India-based company, which manufactures, curates, and makes available online, authentic ayurvedic products in India. The Company’s products includes Ayush Total Health, Liv Muztang Plus, Shilajit Imli Prash, Sampoorna Arogya Herbal Tea, SK Turbo Treats, Vajra 44, Liv Muztang Capsule, Herbo 365 Oil, Addiction Killer, Adivasi Hair Oil, Aadved Bhringraj Oil, Arshoqit, Herbo 365 Capsule, Piles End, Ayush 82 Aadved, Piles Stop, Kaama Gold, Liv Muztang Healthy Shots, Ayush for Women, Addiction Killer Liquid, Liver Care, Nasha Free, Nasha Nivaran, Madhu Nivarani, Ortho Veda Oil, Power Rootz SSS Formulae, Jaam e Ishq, Gaiso Mukt, Ultimate Hammer, Diabaquit, Poshan Plus, Nari Jeevan Jyoti, Stones Veda, Ayush for Men, Ayush Kavach, Sk Pilo, Extra Time, Golden Power, Vayu Shuddhi, Sandy Rx, Ayush Kwath, Aadved Slim Veda, Asthi Urja, Dhurandar Joint Pain Oil, Arokkiyam, Aadved Sleep, Dr Piles Free, and Dr Madhu Amrit.

SAT KARTAR LIFE LIMITED Financial Highlights

  • Revenue: SAT KARTAR LIFE LIMITED reported revenue of ₹203.12 crore in FY26 vs ₹163.68 crore in FY25. It showed an increase of 24.10% on a yearly basis.
  • Operating Profit: SAT KARTAR LIFE LIMITED reported an operating profit of ₹23.22 crore in FY26 vs ₹13.15 crore in FY25. It showed an increase of 76.58% on a year-on-year basis.
  • Net Profit: SAT KARTAR LIFE LIMITED reported a net profit of ₹17.10 crore in FY26 vs ₹9.82 crore in FY25. It showed an increase of 74.13% on a yearly basis.
Know more
Promoters
63.62%
FII
0.13%
Other DII
2.26%
Retail and other
34.00%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
SAT KARTAR LIFE LIMITED Share Price
SAT KARTAR LIFE LIMITED
Pharmaceuticals
Add Stock
Add Another

FAQs on SAT KARTAR LIFE LIMITED Share Price